IL13RA2 and cancer: The expression of IL-13Rα2 mRNA and protein was then analysed in prostate non-cancer (PNT2) and cancer (androgen-dependent (LNCaP) and androgen-independent with a high metastatic potential (DU145 and PC-3)) cell lines via RT-PCR (Figure 1b) and immunoblotting (Figure 1c), respectively.